Protective role of clusterin in preserving endothelial function in AL amyloidosis

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 220-223

  Franco, Daniel A ^a   Truran, Seth ^a   Burciu, Camelia ^a   Gutterman, David D ^b   Maltagliati, Anthony ^a   Weissig, Volkmar ^c   Hari, Parameswaran ^b   Migrino, Raymond Q ^a,b,d  

^a Phoenix Veterans Affairs Health Care System   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Amyloid; Chaperone protein; Endothelial function

Indexed keywords

ACETYLCHOLINE; CLUSTERIN; PAPAVERINE;

ADULT; AMYLOIDOSIS; ARTERIOLE; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENDOTHELIAL FUNCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOIDOSIS; ARTERIOLES; CELL DEATH; CLUSTERIN; DNA FRAGMENTATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; VASODILATION;

EID: 84867867786     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.08.028     Document Type: Article

References (14)

1. Greene M.J., Sam F., Soo Hoo P.T., Patel R.S., Seldin D.C., Connors L.H. Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. Am J Pathol 2011, 178:61-68.
2. Schrijvers E.M., Koudstaal P.J., Hofman A., Breteler M.M. Plasma clusterin and the risk of Alzheimer disease. J Am Med Assoc 2011, 305:1322-1326.
3. Yerbury J.J., Poon S., Meehan S., et al. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 2007, 21:2312-2322.
4. Migrino R.Q., Truran S., Gutterman D.D., et al. Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol 2011, 301:H2305-H2312.
5. Berghoff M., Kathpal M., Khan F., Skinner M., Falk R., Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol 2003, 53:725-730.
6. Migrino R.Q., Hari P., Gutterman D.D., et al. Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 2010, 145:67-68.
7. Modesto K.M., Dispenzieri A., Gertz M., et al. Vascular abnormalities in primary amyloidosis. Eur Heart J 2007, 28:1019-1024.
8. Ando Y., Nyhlin N., Suhr O., et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 1997, 232:497-502.
9. Miani D., Rocco M., Alberti E., Spedicato L., Fioretti P.M. Amyloidosis of epicardial and intramural coronary arteries as an unusual cause of myocardial infarction and refractory angina pectoris. Ital Heart J 2002, 3:479-482.
10. Thambisetty M., Simmons A., Velayudhan L., et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 2010, 67:739-748.
11. Migrino R.Q., Mareedu R.K., Eastwood D., Bowers M., Harmann L., Hari P. Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis. J Am Soc Echocardiogr 2009, 22:1396-1402.
12. Palladini G., Lavatelli F., Russo P., et al. Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL. Blood 2006, 107:3854-3858.
13. Mueller P.S., Edwards W.D., Gertz M.A. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 2000, 109:181-188.
14. Nuutinen T., Suuronen T., Kauppinen A., Salminen A. Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 2009, 61:89-104.